Bibliografía

Zhou Z, Sehn LH, Rademaker AW, Gordon LI, et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014 Feb 6;123(6):837-42